GlobalData, a leading data and analytics company, has found that the COVID-19 pandemic has led to temporarily increased drug sales for big bio/pharma companies in the first quarter (Q1) of 2020. This increase was due to people stockpiling in preparation for limited medical access during the lockdown.
GlobalData’s Pharma Intelligence Center Drug Sales and Forecast Database reveals that global sales in Q1 2020 for companies that were not developing a COVID-19 drug saw an 8% increase in sales when compared to the archived global sales forecast for the same time period. In contrast, companies that were developing a COVID-19 drug only saw a 3% increase.
For more information, click here.
Navigating Distrust: Pharma in the Age of Social Media
February 18th 2025Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceutical companies and the patients they aim to serve. He also explains dark social, how to combat misinformation, closing the trust gap, and more.